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Background: Patient safety during sedation for closed rhizotomies is improved when analgesia is optimised, rather than relying 
on deep sedation for patient comfort. This retrospective study determined the appropriate effect-site concentration (Ce) for 
alfentanil, in combination with a constant propofol infusion, for optimal pain control during sedation for closed rhizotomies. 
Airway maintenance is ensured by keeping patients responsive to verbal commands, albeit at the price of inevitable ventilatory 
depression.
Method: The records of patients who received rhizotomies over a six-month period were studied retrospectively. Sixty-three 
outpatients were included. Patients rated the level of analgesia with each needle placement. If the Ce for alfentanil was adequate, 
it was kept constant. Otherwise, it was increased in 5 ng/ml increments with each needle placement until analgesia was effective, 
or up to the maximum Ce for alfentanil of 100 ng/ml.  Propofol infusion at a constant Ce of 200 ng/ml was added.
Results: Forty-eight per cent of patients reported being comfortable at a Ce for alfentanil of 70–75 ng/ml. Only 5% of patients 
requested the maximum Ce for alfentanil of 100  ng/ml. All of the patients experienced ventilatory depression, but a patent 
airway was maintained. The haemodynamic observations were within normal limits. According to the ward records, 16% of the 
patients complained of nausea, and there was one incident of vomiting.
Conclusion: Combining alfentanil at a Ce for alfentanil of 70–100 ng/ml with propofol at 200 ng/ml is a safe and effective method 
for analgesia during sedation for closed rhizotomies.
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Introduction
Modern technology enables the use of noninvasive methods of 
treating painful pathological conditions. Therefore, the use of 
sedation is an attractive alternative to general anaesthesia for 
transcutaneous neurosurgical procedures, such as radiofrequency 
neurolysis or closed rhizotomy. These procedures are still painful 
and may necessitate deep sedation. Deep sedation borders on 
general anaesthesia,1 and is accompanied by its own perils, of 
which airway obstruction and loss of airway are the most 
common.1,2
Deep sedation can be avoided by maximising analgesia, and 
keeping patients responsive to verbal commands. This benefits 
both the operator and patient. The operator can better locate the 
area of pathology with more exact needle placement through 
patient interaction. Patients maintain a patent airway and are able 
to respond to encouragement to take deep breaths if respiratory 
depression occurs. The patient’s response to verbal commands 
serves as a guide to his or her level of consciousness, and alerts 
the sedationist in the event of the patient drifting into a deeper 
level of sedation. Patients can position themselves on the 
operating table, thereby reducing the chance of a pressure injury.
Alfentanil’s short blood-brain equilibration half-time of 1.1 
minutes3 allows fast and easy titration against painful stimuli. 
Performing a rhizotomy takes approximately 20–30 minutes, and 
necessitates a short recovery time without delayed side-effects. 
Alfentanil’s rapid terminal half-life of 1.6 hours4 and favourable 
context-sensitive half-time5 ensure rapid recovery. Even though 
it is haemodynamically friendly,6,7 its undesirable side-effects, 
including respiratory depression, nausea, itching8 and muscle 
rigidity,9 necessitate careful titration in conscious patients. The 
addition of propofol at subhypnotic doses enhances sedation 
and analgesia through its synergistic effects with alfentanil,10,11 
and also acts as antiemetic.11,12
The purpose of this retrospective study was to define the 
appropriate targeted effect-site concentration (Ce) for alfentanil, 
to be administered in conjunction with a targeted propofol 
infusion of 200  ng/ml, in order to optimise analgesia and 
sedation for closed rhizotomies. Patient safety and operating 
conditions during the procedure were evaluated, as well as 
recovery afterwards.
Method
Approval was granted by the South African Medical Association 
Research and Ethics Committee. The records of patients who 
received a closed rhizotomy over a six-month period from June 
to November 2009 were reviewed. The reasons for patient 
exclusion are shown in Table 1. Patients aged 70 years and older 
were excluded because of the use of a lower initial targeted 
alfentanil concentration.
Patients were fasted and admitted as day cases. The same 
anaesthesiologist performed the pre-procedure medical history 
and examination, as well as sedation in all of the cases. 
Rhizotomies were performed in the operating room by the same 
neurosurgeon. Premedication was not used. Patients assumed 
the prone position on the operating table. Supplemental oxygen, 
at two litres per minute, was administered using nasal prongs 
containing a gas-sampling port, i.e. Salter Style® Nasal Cannula 
(Adult) (Salter Labs, Arvin, USA).  Respiratory rate (RR) and end-
tidal carbon dioxide (EtCO2) were monitored with capnography, 
together with systolic noninvasive blood pressure (NIBPS) and 
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diastolic noninvasive blood pressure, pulse oximetry [oxygen 
saturation (SpO2)], pulse rate [heart rate (HR)] and bispectral index 
(BIS) (Philips Medizinsystems, Boeblingen, Germany).
An intravenous line was established, through which crystalloids 
and drugs were given. Baseline observations were recorded after 
the patient was settled and comfortable (observation point 1). 
Patients received 1 mg granisetron intravenously directly before 
the start of the sedation to prevent nausea and vomiting. Local 
analgesia was not used. Pajunk® Facet Denervation Needles 22 G 
x 100 mm (Pajunk, Geisingen, Germany) were used for the rhizot-
omy and a 20 G 3.5 inch Becton Dickinson® spinal needle (Becton 
Dickinson and Company, Madrid, Spain) for the caudal injection 
of betamethasone.
Two separate target-controlled infusion pumps, i.e. Alaris® PK 
Syringe pumps (Alaris Medical UK Ltd, Basingstoke, UK) were 
used. For the first pump, a 50 ml syringe was filled with alfentanil 
and diluted with normal saline to 100 μg/ml. Patient data were 
entered into the infusion pump software using the Maître 
pharmacokinetic parameter set for alfentanil.13 The Ce was 
targeted to start at 70 ng/ml.
The second pump was fitted with a 20 ml syringe containing 1% 
propofol and set up using the Schnider pharmacokinetic 
parameter set14 with a constant targeted Ce of 200  ng/ml. This 
infusion was started as soon as the calculated Ce for alfentanil 
was achieved. When the calculated Ce for propofol was reached, 
another set of observations were obtained (observation point 2), 
after which the first rhizotomy needle was placed. During each 
needle placement, observations were recorded together with 
patient movement and level of analgesia. Patient movement was 
scored by the operator as an indication of operating conditions as 
follows: 0 = no movement, 1 = a flicker of movement, 2 = tensing 
of the back muscles and 3  =  movement interrupting needle 
placement. The number of incidents of movement was not taken 
into account.
The patient rated the quality of analgesia as being either sufficient 
or insufficient, and these responses determined the Ce for 
alfentanil for the next needle placement as follows: if analgesia 
was adequate, the Ce for alfentanil was kept constant, and the next 
needle was placed. Otherwise, the Ce for alfentanil was increased 
stepwise in 5  ng/ml increments with each following needle 
placement until the patient was comfortable or up to a maximum 
of 100 ng/ml. With each increase in Ce for alfentanil, there was a 
waiting period for the calculated alfentanil concentration to reach 
the set target before the next needle was placed. This was repeated 
with each needle placement. A consistent order and number of 
needle placements was used for the patients in each group: 10 
needle placements (observation points 3–12) for cervical (C) 
rhizotomies right C7–C3 and left C3–C7; and nine needle 
placements (observation points 3–11) for lumbar (L) rhizotomies 
left L3–L5, left sacral (S)1, caudal, right L3–L5 and right S1.The 
lumbar procedure was performed first in patients who received a 
lumbar and cervical rhizotomy, followed by the cervical procedure 
with needle placement in the same order as that set out previously 
(19 needle placements, observation points 3–21).
BIS was used to monitor the level of sedation. Clinical sedation 
scores were not recorded. However, patients had to indicate 
whether or not the level of analgesia was sufficient at each 
observation point. The patients’ responses to the verbal 
commands served as a clinical guide to their level of consciousness.
Both infusions were discontinued after the last needle placement. 
Supplemental oxygen was stopped with completion of the 
procedure. Patients were assisted in turning from the prone 
position on the operating table to the supine position on their 
beds. Recovery room staff performed standard postoperative 
monitoring and determined each patient’s readiness for discharge 
to the ward. These records were used to evaluate post-procedure 
patient safety. Ventilation on room air was considered to be 
adequate if oxygen saturation (SpO2) was equal to or above 90% 
and RR at least 10/minute. Intravenous naloxone 0.4  mg was 
available if the RR was below 10/minute, as well as intravenous 
ondansetron 4 mg for nausea and vomiting.
The ward records were scanned for possible late adverse effects.
The haemodynamic changes in HR and NIBPS were calculated for 
each patient as a percentage change from the previous 
observation point. Descriptive statistics were used to characterise 
these changes as an average percentage change for patients at 
each observation point.
Pearson’s product-moment correlation co-efficient test was 
performed to determine whether or not there was a relationship 
between the Ce for alfentanil and movement. One-way analysis of 
variance was used to determine differences in the means of 
duration of stay in recovery against the maximum Ce for alfentanil 
reached, dose rate per kg and duration of the procedure.
The data were analysed using Statistical Software for Social 
Sciences® 19.0.
Results
During the six-month period, 108 rhizotomies were performed, 
of which 45 were excluded (Tables 1 and 2). The analgesic effect 
was rated according to the maximum Ce for alfentanil needed 
for patient comfort (Table 3). Forty-eight per cent of the patients 
were comfortable at a Ce for alfentanil of 70–75  ng/ml. Only 
three patients (5%) needed the maximum allowed Ce for 
alfentanil of 100 ng/ml. Of these, one patient was comfortable 
for the remainder of the procedure, while the other two 
continued to experience some discomfort during the needle 
placements.
All of the patients were able to respond verbally when questioned 
about their comfort level. The mean BIS for all of the observation 
points in the patients was 91.1 [standard deviation (SD) 4.95] 
Table 1: Reasons for patient exclusion
Reason for exclusion Number
Refused sedation 3
Additional procedures performed 7
Vasovagal attack before the start of sedation 1
Faulty infusion pump 1
Patient aged 70 years and older 9
Non-functional bispectral index 1
A different protocol was used 9
Language barrier 2
Weight out of range for the Schnider model 4
Patient with upper respiratory tract infection; refused 
postponement
1
Data not available 7
Total 45
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(Figure 1). Five patients had at least one BIS reading below 70. 
However, they responded verbally when prompted.
Haemodynamic changes during the procedure are shown in 
Figures 2 (HR) and 3 (NIBPS). The average percentage change in 
HR at each observation point for all patients varied between −4% 
and 6% (Figure 2). There was no incident of bradycardia (HR less 
than 50/minute). The average percentage change in systolic 
blood pressure at each observation point for all the patients 
varied between −2% and 4% (Figure 3).
As expected, the RR decreased after the induction of sedation 
(Figure 4), with one episode of witnessed apnoea (loss of CO2 
trace) that resolved immediately when the patient was prompted 
to take deep breaths. Figure 5 shows the gradual increase in EtCO2 
over time. The lowest SpO2 recorded was 90%.
Twenty-eight patients (44%) did not move at all during the 
needle placements and the operating conditions were excellent 
(Table 4). Twenty-one per cent (13 patients) moved to the extent 
that needle placement was interrupted. For half of these patients 
this only occurred once during the procedure, and was resolved 
when they were reminded to keep still. It is possible that factors 
other than pain contributed to incidents of movement, e.g. anxiety. 
One patient moved to some extent with each needle placement. This 
patient indicated that there was no need for more analgesia with 
each needle placement, and reached a maximum Ce for alfentanil 
of only 70 ng/ml. Statistical analysis showed no correlation between 
the maximum Ce for alfentanil and movement (Pearson’s product- 
moment correlation coefficient = −0.026, p = 0.825).
Some patients exhibited wrist and finger flexion at the higher end 
of the dosage spectrum, as described by McDonnell et al.15 It is 
uncertain whether or not this was part of the phenomenon of 
muscle rigidity during opioid use.
The recovery room sedation score, as determined by the recovery 
room staff, was 5/5 for all but two patients (Table 5). Of these two, 
one scored 4/5 because of the presence of pain, and the other 
scored 2/5, being “unresponsive to verbal commands”, and scored 
0 for muscle control and the presence of pain. All of the patients 
sustained adequate spontaneous ventilation. The lowest SpO2 
recorded was 92% on room air. No supplemental oxygen was 
required and naloxone was not needed. On discharge to the 
ward, the lowest recorded SpO2 was 93%. The patients remained 
haemodynamically stable. Bradycardia and hypotension were not 
recorded. The average time spent in the recovery room was 16.5 
minutes, from arrival until discharge to the ward. The correlation 
analysis showed that no variable (the maximum Ce for alfentanil 
reached, dose rate/kg and duration of the procedure) significantly 
correlated with the time spent in the recovery area (p > 0.05).
The ward records indicated that 10 (16%) patients reported nausea, 
one of whom vomited. Dizziness was mentioned in the records of 
four patients. One of these fell down when using the bathroom.
Table 2: Patient demographics
Number of patients Total (63) Male (26) Female (37)
Number of patients per procedure Lumbar (23) Cervical (30) Lumbar and cervical (10)
Mean (SD) Minimum Maximum
Age (years) 43 (11.00) 23.00 70.00
Weight (kg) 77.6 (14.90) 45.00 115.00
Height (m) 1.70 (0.09) 1.55 1.94
Body mass index (kg/m²) 28.01 (9.02) 16.90 36.00
Note: SD: standard deviation
Figure 1: Bispectral index values
Note: BIS: bispectral index, max: maximum min: minimum




70 75 80 85 90 95 100
Number (%) of 
patients
17 (27) 13 (21) 10 (16) 6 (10) 9 (14) 5 (8) 3 (5)
Mean total dose 
alfentanil (μg); 
(SD, 95% CI) 
2 101 (363, ± 124.5) 2 157 (448, ± 244) 2 242 (387, ± 240) 2 392 (413, ± 330) 2 449 (872, ± 697) 3 064 (925, ± 810) 3 077 (975, ± 1 103)
Mean duration of 
infusion (minutes)
21.2 18.7 20.2 21.8 24.1 23.2 24.6
Mean alfentanil 
dose rate per kg 
(μg/kg/minute)
1.30 1.50 1.50 1.56 1.59 1.58 1.6
Note: Ce: effect-site concentration, CI: confidence interval, SD: standard deviation
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The optimal Ce for alfentanil should provide maximum pain relief 
with minimum side-effects. Alfentanil’s analgesic effects are dose 
related16 and vary between 40  ng/ml10,17 and 110  ng/ml8 for 
effective postoperative analgesia. Pavlin et al10 found that 
combining propofol and alfentanil could produce sedation and 
analgesia that was greater than that observed with either drug 
alone. They stated that plasma propofol concentrations in excess 
of 800  ng/ml, especially when combined with alfentanil, were 
associated with “extensive sedation and tendency toward upper 
airway obstruction”.10 Their study demonstrated loss of “alertness 
and increased sedation” at target plasma propofol concentrations 
as low as 150 ng/ml, in the presence of a target alfentanil infusion 
of only 40  ng/ml. Vuyk et al18 modelled the expected optimal 
propofol and alfentanil concentration combinations associated 
with adequate anaesthesia that would result in the most rapid 
recovery after termination of target controlled infusions of 
different durations. They estimated that the plasma alfentanil 
concentration at which awakening occurs vary between 64.6 ng/
ml and 73  ng/ml in the presence of much higher propofol 
concentrations than that used in the current study.
Based on the Vuyk study18 the Ce for alfentanil in our study, starting 
at 70  ng/ml, combined with a very modest target propofol 
concentration of 200 ng/ml, was chosen to ensure analgesia with 
some sedation without causing loss of consciousness.
Some studies also suggest that subhypnotic doses of propofol 
reduce sensitivity to pain.10,19,20 Therefore, it is possible that propofol 
reduced pain by itself, apart from its synergistic analgesic effects 
Discussion
The purpose of this retrospective study was to define the 
appropriate targeted Ce for alfentanil in order to optimise 
analgesia for closed rhizotomies, without causing deep sedation. 
The therapeutic window for alfentanil was regarded as 70–
100  ng/ml in the presence of a constant subhypnotic target-
controlled infusion of 200 ng/ml propofol.
Figure 2: Percentage change in the heart rate from the preceding observation point.
 Note: HR: heart rate, SD: standard deviation
Figure 3: Percentage change in systolic blood pressure (noninvasive blood pressure monitors) from 
the preceding observation point
Note: NIBPS: non-invasive blood pressure systolic
Figure 4: Mean and minimum respiratory rate
Note: RR: respiratory rate
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Several studies demonstrated that the BIS is a sensitive measure 
of depth of sedation,22,23 and also correlates with the observer’s 
assessment of awareness and sedation scale (OAA/S) (5 = responds 
readily to name called in a normal tone to 1 = does not respond to 
mild prodding or shaking).22,23 Data from the study by Liu et al 
suggested that a BIS value of 85–90 correlated with an OAA/S 
score of 3 (responds only if name is called out loudly or repeatedly). 
The OAA/S was not recorded in the present study. However, since 
all of the patients were able to respond when questioned about 
their level of analgesia, and none of them needed prodding or 
shaking in order for a response to be elicited, it can be assumed 
that they were sedated to a level of at least 3–5 using the OAA/S. 
This correlates with the mean BIS value of 91.1 (SD 4.95) in the 
present study. It is possible that patient arousal was caused by the 
painful stimulus of the needle placements, as well as the regular 
verbal questioning regarding the patient’s level of analgesia, and 
might have affected the BIS. Furthermore, reports have suggested 
that BIS values may be influenced by the types of drugs used. The 
addition of fentanyl, nitrous oxide or alfentanil to a propofol 
anaesthetic increased the BIS value at which loss of response to 
voice command occurred.24–26 The individual BIS scores also 
showed wide variability, as seen in the minimum BIS score 
recorded at each observation point (Figure 1). BIS values between 
65 and 85 have been recommended for sedation, while values 
from 45–60 have been recommended for general anaesthesia.27 
The mean BIS values over all of the observation points indicated 
when combined with alfentanil. Pavlin et al10 reported that the 
analgesic synergism between propofol and alfentanil appeared to 
plateau at a plasma alfentanil concentration beyond approximately 
100 ng/ml.
All of the patients remained conscious for the duration of the 
procedure, even though the alfentanil dose rate expressed as μg/
kg/minute (Table 3) was high compared to the mean maintenance 
rate of 0.45 μg/kg/minute used in the study by Sherry,21 and that 
of 0.3  μg/kg/minute (20  μg/kg/hour) by O’Connor et al.8 Thirty 
patients (48%) were comfortable at a Ce for alfentanil of 70–75 ng/
ml and 60 (95%) at a Ce for alfentanil of 70–95 ng/ml. Therefore, a 
Ce for alfentanil of 70–75 ng/ml can be regarded as a good starting 
point, and can be titrated upwards, if necessary. Only three 
patients (5%) required the maximum Ce for alfentanil of 100 ng/
ml. After the maximum Ce for alfentanil was reached, two of the 
three patients continued to experience some discomfort during 
some of the needle placements. It is possible to enhance patient 
comfort in this small subset by increasing the Ce for propofol, 
taking into account that patients may drift into deep sedation 
with clinically important respiratory depression and loss of airway. 
To prevent this, patient responses must be monitored carefully 
throughout the procedure. Further studies are necessary to 
determine the optimal alfentanil and propofol combination to 
gain maximum analgesia without impeding consciousness.
Table 4: Maximum movement score observed
Maximum movement score observed* 0 1 2 3
 Number (%) of patients 28 (44) 9 (14) 13 (21) 13 (21)
*: 0 = no movement; 1 = flicker of movement; 2 = tensing of back muscles; 3 = movement interrupting needle placement.
Figure 5: Mean and maximum end-tidal carbon dioxide.
Notes: EtC02: end-tidal carbon dioxide
Table 5: Recovery room scoring system
Level of consciousness Responsive to verbal commands 1
Unresponsive to verbal commands 0
Systolic blood pressure  ≥ 90 mmHg 1
< 90 mmHg 0
Colour and perfusion Skin: Normal and warm 1
Skin: Pale, cold and cyanosed 0
Muscle control: Lift head for five seconds and grip hand firmly Patient able to do this 1
Patient unable to do this 0
Pain Pain free 1
Pain present 0
Score required for discharge to ward 5
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Propofol is useful for its antiemetic properties.10 The plasma 
concentration of propofol for a 50% reduction in the nausea 
scores in a group of postoperative patients was 343 ng/ml.32 The 
Ce for propofol of 200 ng/ml used in the present study is in line 
with that of Schulman et al,33 who determined the plasma 
concentration of propofol for the successful treatment of nausea 
in a postoperative patient to be 197  ng/ml. In spite of the 
antiemetic prophylaxis with granisetron and the use of propofol 
in the infusion, a total of 10 patients (nine females and one male), 
i.e. 16% postoperatively, reported nausea, one of whom vomited. 
All of the cases resolved after a 4 mg bolus dose of ondansetron 
intravenously. It is interesting to note that all the cases of nausea, 
as well as the one case of vomiting, occurred when the patients 
were already back in the ward. It is uncertain if this related to food 
intake or mobilising the patients. The ward notes also indicated 
four cases of dizziness, with one patient falling down. It is 
unknown whether this was because of dizziness or owing to 
temporary muscle weakness after the lumbar rhizotomy.
The minimum alfentanil plasma or Ce at which muscle rigidity 
occurs is not known. Nauta et al34 described the “ideal rate of 
alfentanil infusion in terms of minimising chest wall rigidity and 
induction time” as being 50 ug/kg/minute. Through computer 
simulation, it is estimated that an infusion rate of 50 ug/kg/
minute alfentanil should result in steady state plasma and a Ce 
above 300 ng/ml. This is well above the maximum Ce for alfentanil 
of 100 ng/ml used in this study.
The use of opioids commonly causes pruritis.17 The incidence of 
pruritus in this study was not recorded. An itchy nose was 
mentioned by some patients, but was not disruptive to the 
procedure.
There were limitations to this retrospective study. The plasma 
levels of alfentanil and propofol were not measured. It is possible 
that the actual plasma and the Ce for alfentanil and propofol were 
higher than the predicted values because of pharmacokinetic 
and pharmacodynamic interactions. Owing to pharmacokinetic 
variability, infusions must be titrated and adjusted for each 
individual patient. When generalising the findings to elderly and 
sick patients, it is essential to start the Ce for alfentanil at the 
lower end of the therapeutic window. As a safety precaution, 
the opioid should be started first in order to evaluate its sedative 
effects before propofol is added. It may be valuable to increase 
the Ce for propofol in patients who are not comfortable even at a 
higher Ce for alfentanil until the desired level of sedation and pain 
control is achieved. Patient responsiveness needs to be monitored 
carefully, as higher doses of propofol may cause excessive 
sedation, airway obstruction and delayed recovery.
Remifentanil often replaces alfentanil in sedation for painful 
procedures. Even though its pharmacokinetic profile is very similar 
to that of alfentanil,35 its potency (20 times more potent than 
alfentanil)35 and its rapid breakdown by tissue and blood esterases 
are its greatest assets. During sedation, a remifentanil infusion is 
often combined with a propofol infusion. Owing to remifentanil’s 
ultra-short, context-sensitive half-time, a rapid return of 
consciousness is certain, even after a prolonged infusion.18 More 
research is needed to determine the remifentanil dose range at 
which patients will be comfortable during rhizotomies.
The fact that remifentanil can be harmful in inexperienced hands 
has led to a recommendation in the South African Society of 
Anaesthesiologists sedation guidelines that it should not be used 
outside the hospital environment.36
that the BIS score remained well above the level of deep sedation 
and general anaesthesia (Figure 1).
Clinically important ventilatory depression was expected to occur 
at a Ce for alfentanil of 100 ng/ml, based on work carried out by 
O’Connor et al.,8 and Andrews et al.,28 who determined that 
moderate respiratory depression occurred at stable alfentanil 
plasma concentrations of 108 ng/ml and 120 ng/ml, respectively. 
The influence on spontaneous breathing, when an opioid and a 
hypnotic were combined, was obvious as witnessed by the 
decrease in RR (Figure 4) and increase in EtCO2 (Figure 5). However, 
since the patients remained responsive to verbal commands, they 
were able to oblige requests to take deep breaths. More 
importantly, there were no cases of airway obstruction, and even 
at a higher Ce for alfentanil, intervention was not required to 
maintain a patent airway. There was also no need to reduce the 
rate of either infusion.
The lack of cardiovascular depression during the procedure 
confirmed the haemodynamic safety of the drug combination 
when carefully titrated to the desired Ce. Furthermore, the fairly 
constant mean HR and NIBPS over all of the observation points 
confirmed the ability of opioids, in this case, alfentanil, to blunt 
the autonomic responses that follow a noxious stimulation. It 
then seems that alfentanil, through its action on the opioid 
receptors in the spinal cord, successfully prevented the noxious 
stimulus from reaching the higher centres in the brain.
There was no relationship between the Ce for alfentanil reached 
in each patient and the movement score during the needle 
placements in patients who received either a cervical or lumbar 
rhizotomy. There was a clear relation between movement score 
and the Ce for alfentanil reached in patients who received both a 
lumbar and cervical rhizotomy. This may be explained by the 
longer duration of these procedures versus the individual lumbar 
or cervical procedures. Pavlin et al10 found that when propofol 
and alfentanil were given in combination, a pharmacokinetic 
interaction occurred that led to an increased plasma concentration 
of both drugs. It is possible that owing to the longer duration of 
infusion during the combined procedure, the actual Ce of both 
the drugs was higher than that predicted by the infusion pump. 
This possibility is in line with the gradual decline observed in the 
average BIS values from observation point 13 onwards.
The postoperative period is very important as far as safety is 
concerned. Lingering drugs may cause patients to drift into 
deeper levels of sedation once the stimulation of the procedure 
has been withdrawn.1,29 This was possibly the case for the one 
patient in the present study who scored 2/5 for being 
“unresponsive to commands” on arrival in the recovery room. 
However, the postoperative records indicate that the patient did 
not need airway intervention, breathing spontaneously at 16/
minute and with a SpO2 of 100% on room air. This patient’s 
recovery room stay was 17 minutes, comparable to the average in 
this study. The importance of monitoring patients after sedation 
was underscored by this incident.
Recurrent respiratory depression after alfentanil infusion is one 
possibility with respect to late adverse effects. It has been 
described over a wide range of doses and duration of infusions,29–31 
occurring approximately 45 minutes after the infusion was 
stopped. According to the postoperative ward records, there 
were no cases of recurrent respiratory depression in any of the 
patients in the present study.
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The results of this retrospective study indicate that the 
combination of alfentanil, at a Ce for alfentanil of 70–100 ng/ml, 
and propofol at 200  ng/ml, is a safe and effective method for 
analgesia during sedation for closed rhizotomies. By effectively 
controlling the patients’ pain during needle placement, it was 
possible to keep them responsive to verbal commands and to 
avoid deep sedation with airway compromise. Alfentanil should 
be carefully titrated upwards while patients are being adequately 
monitored.
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